Publications by authors named "Conleth Murphy"

Claim this Profile
T
TCHL - a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, trastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis.
John Crown, Alex J Eustace, Denis M Collins, Maccon Keane, Linda Coate, Conleth Murphy

Acta Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summary.
Kathleen N Moore, Domenica Lorusso, Ana Oaknin, Amit Oza, Nicoletta Colombo, Conleth G Murphy

Gynecol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial.
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore Denys, Conleth Murphy

Int J Gynecol Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Z.R. McCaw et al.
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Conleth G Murphy

J Clin Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Conleth G Murphy

J Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer outcomes in a private hospital appear better than national outcomes in a country with a mixed public/private healthcare model.
Michael Killian, Deirdre O' Mahony, Kate Murphy, Derbrenn O' Connor, Brian Bird, Conleth G Murphy

Ir J Med Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland.
Cathriona Kearns, Ronan Feighery, John Mc Caffrey, Michaela Higgins, Martina Smith, Verena Murphy, Conleth Murphy

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-related fatigue and self-care agency: A multicentre survey of patients receiving chemotherapy.
Patricia O'Regan, Geraldine McCarthy, Seamus O'Reilly, Derek Power, Brian Healey Bird, Conleth G Murphy

J Clin Nurs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Need for Increased Melanoma Awareness among Non-dermatology Secondary Care Colleagues.
Catherine Quinlan, Stephen McCracken, Emma Tierney, Cynthia Heffron, James Fitzgibbon, Conleth Murphy, Michelle Murphy

Acta Derm Venereol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of CDK4/6 Inhibitors in Breast Cancer.
Conleth G Murphy

Curr Treat Options Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells.
Shuhei Ito, Conleth G Murphy, Ekaterina Doubrovina, Maria Jasin, Mary Ellen Moynahan

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease.
Alina Mihai, Yijia Mu, John Armstrong, Mary Dunne, Sushil Beriwal, Conleth Gerard Murphy

J Radiosurg SBRT· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies.
Conleth G Murphy, Maura N Dickler

Endocr Relat Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine aspiration thrombectomy improves the diagnosis and management of embolic myocardial infarction.
Alex L Huang, J Conleth Murphy, Elizabeth Shaw, Rebecca Kozor, Warren Yan

Catheter Cardiovasc Interv· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 inhibitors in breast cancer.
Tim Dukelow, Divya Kishan, Mustafa Khasraw, Conleth G Murphy

Anticancer Drugs· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significance.
Paul Ryan, Heidi Furlong, Conleth G Murphy, Finbarr O'Sullivan, Thomas N Walsh

Cancer Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of CDK4/6 Inhibition in Breast Cancer.
Conleth G Murphy, Maura N Dickler

Oncologist· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study.
Aki Morikawa, David M Peereboom, Helen R Thorsheim, Ramakrishna Samala, Rajiv Balyan, Conleth G Murphy

Neuro Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of patupilone in patients with brain metastases from breast cancer.
David M Peereboom, Conleth Murphy, Manmeet S Ahluwalia, Alison Conlin, April Eichler

Neuro Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited overall survival in patients with brain metastases from triple negative breast cancer.
Patrick G Morris, Conleth G Murphy, Divya Mallam, Melissa Accordino, Sujata Patil

Breast J· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in novel targeted therapies for HER2-positive breast cancer.
Conleth G Murphy, Patrick G Morris

Anticancer Drugs· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.
Conleth G Murphy, Divya Mallam, Samantha Stein, Sujata Patil, Jane Howard

Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phyllodes tumor of the breast.
Grzegorz Korpanty, Derek G Power, Conleth Murphy, Malcolm Kell, John McCaffrey

Med Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystoid macular edema secondary to nab-paclitaxel therapy.
Conleth G Murphy, Joseph B Walsh, Clifford A Hudis, Diana Lake, Maria Theodoulou

J Clin Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-positive breast cancer: beyond trastuzumab.
Conleth G Murphy, Monica Fornier

Oncology (Williston Park)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis